Research loss in Pfizer-Wyeth deal
Pfizer's $68 billion merger with Wyeth, which officially linkurl:commences today,;https://www.pfizer.com/news/press_releases/pfizer_press_releases.jsp?rssUrl=https://mediaroom.pfizer.com/portal/site/pfizer/index.jsp?ndmViewId=news_view&ndmConfigId=1016273&newsId=20091015006478&newsLang=en will mean the loss of almost 20,000 jobs, the company has said, and analysts predict research could take a hard hit. The deal involves combining laboratories of the once-competing companies. Martin Mackay, pres
Written byAlla Katsnelson
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
**__Related stories:__***linkurl:Merck and Schering-Plough to merge;https://www.the-scientist.com/blog/display/55497/
[9th March 2009]*linkurl:How to save biotech;https://www.the-scientist.com/news/display/55425/
[17th February 2009]*linkurl:The urge to merge;https://www.the-scientist.com/article/display/14931/
[13th September 2004]
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred Google source to see more of our trusted coverage.
Meet the Author
- This person does not yet have a bio.View Full Profile
